Diabetes, Obesity and Metabolism

Diabetes, Obesity and Metabolism
Pubblicazione: (2024)

Diabetes, Obesity and Metabolism
Pubblicazione: (2024)

Diabetes, Obesity and Metabolism
Pubblicazione: (2024)

Diabetes, Obesity and Metabolism
Pubblicazione: (2024)

Diabetes, Obesity and Metabolism
Pubblicazione: (2026)

Diabetes, Obesity and Metabolism
Pubblicazione: (2025)

Diabetes, Obesity and Metabolism
Pubblicazione: (2025)

Diabetes, Obesity and Metabolism
Pubblicazione: (2026)

Diabetes, Obesity and Metabolism
Pubblicazione: (2025)

Diabetes, Obesity and Metabolism
Pubblicazione: (2025)

Diabetes, Obesity and Metabolism
Pubblicazione: (2026)

Diabetes, Obesity and Metabolism
Pubblicazione: (2025)

Diabetes, Obesity and Metabolism
Pubblicazione: (2025)

Diabetes, Obesity and Metabolism
Pubblicazione: (2025)

Diabetes, Obesity and Metabolism
Pubblicazione: (2025)

The Duodenal Mucosa Plays a Key Role in Metabolic Regulation: Emerging Physiology and New Opportunities for Cell‐Directed and Barrier‐Related Interventions for the Treatment of Diabetes and Obesity
di: David A. D’Alessio, et al.
Pubblicazione: (2026)

Association of Physical Activity With All‐Cause and CVD Mortality Across Metabolic and Obesity Phenotypes
di: Yunmin Han, et al.
Pubblicazione: (2026)

Real‐World Cardiovascular Outcomes of Obesity Treatment With Tirzepatide Versus Semaglutide in Non‐Diabetic Adults
di: Mai Katsura, et al.
Pubblicazione: (2026)

Coexisting Asthma and Diabetes Are Associated With Adverse Metabolic and Inflammatory Profiles
di: Sixtus Aguree, et al.
Pubblicazione: (2026)

Obesity and Metabolic Dysfunction‐Associated Steatotic Liver Disease ( MASLD ): A Literature Review on Pathophysiology and Treatment
di: Michael Romanos, et al.
Pubblicazione: (2026)

Waist‐to‐Height Ratio and the Risk of Cardiovascular Outcomes and Mortality in Type 2 Diabetes With and Without Abdominal Obesity
di: Kye‐Yeung Park, et al.
Pubblicazione: (2026)

The Burden of Obesity and Type 1 Diabetes: Distinct and Synergistic Effects to Worsen Perceived Health and Psychosocial Distress
di: Renata Risi, et al.
Pubblicazione: (2026)

Enriched Metabolic Phenotyping Refines Phenotypic Resolution of Type 2 Diabetes
di: Min Wang, et al.
Pubblicazione: (2026)

REduced‐Carbohydrate intervention for managing Obesity and Reduction of gestational Diabetes ( RECORD ): A randomized controlled feasibility trial
di: Moscho Michalopoulou, et al.
Pubblicazione: (2024)

Associations of Visceral Obesity Indices and Risk of Mild Cognitive Impairment in Patients With Diabetes: A Retrospective Cohort Study
di: Jingyi Jiao, et al.
Pubblicazione: (2026)

Beyond GLP ‐1 Monotherapy: Novel Multi‐Agonists, Amylin Analogues, and Combination Strategies in Obesity and Type 2 Diabetes
di: Mikhail Khachaturov, et al.
Pubblicazione: (2026)

Prevalence of Cardiovascular‐Kidney‐Metabolic Conditions Across Body Mass Index Categories: The Distinct Burden of Severe (Class III ) Obesity
di: Saif S. Rathore, et al.
Pubblicazione: (2026)

Efficacy and Safety of Mazdutide in Managing Overweight and Obesity Among Non‐Diabetic Adults: A Meta‐Analysis of Randomised Controlled Trials
di: Muhammad Hassan Azam, et al.
Pubblicazione: (2026)

Exercise Metabolic Flexibility in Type 2 Diabetes Treated With Empagliflozin: An Exploratory Analysis of the Randomised Trial EMPA ‐ HEART
di: Lorenzo Nesti, et al.
Pubblicazione: (2026)

Meta‐analysis of randomized controlled trials for the development of the International Federation for Surgery of Obesity and Metabolic Disorders‐European Chapter (IFSO‐EC) guidelines on multimodal strategies for the surgical treatment of obesity
di: Maurizio De Luca, et al.
Pubblicazione: (2025)

Adherence to the EAT ‐Lancet Diet, Genetic Susceptibility and Risk of Obesity and Obesity‐Related Morbidities: A Prospective Cohort Study
di: Huan‐Cong Zheng, et al.
Pubblicazione: (2026)

Real‐World Clinical Evidence of Tirzepatide for Metabolic Abnormalities in Subjects With Type 2 Diabetes: The Multicenter Retrospective Observational Hokkaido‐ TZP Study
di: Fumika Maruyama, et al.
Pubblicazione: (2026)

Serum Short‐Chain Fatty Acid Profiles as Metabolic Signatures of Diabetic Cognitive Impairment: Multinomial Modelling and Internally Validated Multiclass Discrimination
di: Jie Zheng, et al.
Pubblicazione: (2026)

Obesity mortality on the rise: A 54‐year US perspective
di: Jazza Aamir, et al.
Pubblicazione: (2025)

Obesity in Late Adolescence and Healthcare Costs in Young to Mid‐Adulthood
di: Cheli Melzer Cohen, et al.
Pubblicazione: (2026)

Efficacy, Safety and PK of Once‐Daily Oral Semaglutide 25 mg for Obesity With and Without Type 2 Diabetes in Comparison With Subcutaneous Semaglutide 2.4 mg: A Model‐Informed Drug Development Approach
di: Rune Viig Overgaard, et al.
Pubblicazione: (2026)